» Articles » PMID: 20674794

Emerging, Novel, and Known Influenza Virus Infections in Humans

Overview
Date 2010 Aug 3
PMID 20674794
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza viruses continue to cause yearly epidemics and occasional pandemics in humans. In recent years, the threat of a possible influenza pandemic arising from the avian influenza A(H5N1) virus has prompted the development of comprehensive pandemic preparedness programs in many countries. The recent emergence of the pandemic influenza A(H1N1) 2009 virus from the Americas in early 2009, although surprising in its geographic and zoonotic origins, has tested these preparedness programs and revealed areas in which further work is necessary. Nevertheless, the plethora of epidemiologic, diagnostic, mathematical and phylogenetic modeling, and investigative methodologies developed since the severe acute respiratory syndrome outbreak of 2003 and the subsequent sporadic human cases of avian influenza have been applied effectively and rapidly to the emergence of this novel pandemic virus. This article summarizes some of the findings from such investigations, including recommendations for the management of patients infected with this newly emerged pathogen.

Citing Articles

Screening and Validation of Odorants against Influenza A Virus Using Interpretable Regression Models.

Jasial S, Hu J, Miyao T, Hirama Y, Onishi S, Matsui R ACS Pharmacol Transl Sci. 2023; 6(1):139-150.

PMID: 36654744 PMC: 9841774. DOI: 10.1021/acsptsci.2c00193.


A Therapeutically Active Minibody Exhibits an Antiviral Activity in Oseltamivir-Resistant Influenza-Infected Mice via Direct Hydrolysis of Viral RNAs.

Lee Y, Hoang P, Kim D, Ayun R, Luong Q, Na K Viruses. 2022; 14(5).

PMID: 35632846 PMC: 9146509. DOI: 10.3390/v14051105.


Evolutionary pressures rendered by animal husbandry practices for avian influenza viruses to adapt to humans.

de Camargo M, Caetano A, Ferreira de Miranda Santos I iScience. 2022; 25(4):104005.

PMID: 35313691 PMC: 8933668. DOI: 10.1016/j.isci.2022.104005.


Association between plasma glycocalyx component levels and poor prognosis in severe influenza type A (H1N1).

Huang X, Lu F, Tian H, Hu H, Ning F, Shang Q Sci Rep. 2022; 12(1):163.

PMID: 34997090 PMC: 8741814. DOI: 10.1038/s41598-021-04146-2.


Meta-Analysis of the Diagnostic Efficacy of the Luminex xTAG Respiratory Viral Panel FAST v2 Assay for Respiratory Viral Infections.

Xie L, Yin X, Xie T, Su J, Huang Q, Zhang J Yonsei Med J. 2021; 63(1):95-103.

PMID: 34913289 PMC: 8688366. DOI: 10.3349/ymj.2022.63.1.95.


References
1.
Smith G, Vijaykrishna D, Bahl J, Lycett S, Worobey M, Pybus O . Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 2009; 459(7250):1122-5. DOI: 10.1038/nature08182. View

2.
Vaillant L, La Ruche G, Tarantola A, Barboza P . Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill. 2009; 14(33). DOI: 10.2807/ese.14.33.19309-en. View

3.
Gupta R, George R, Nguyen-Van-Tam J . Bacterial pneumonia and pandemic influenza planning. Emerg Infect Dis. 2008; 14(8):1187-92. PMC: 2600366. DOI: 10.3201/eid1408.070751. View

4.
. Neurologic complications associated with novel influenza A (H1N1) virus infection in children - Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep. 2009; 58(28):773-8. View

5.
Yamada T . Poverty, wealth, and access to pandemic influenza vaccines. N Engl J Med. 2009; 361(12):1129-31. DOI: 10.1056/NEJMp0906972. View